Agios presents encouraging results of leukemia drug trial

04/6/2014 | Forbes · Reuters

In the first clinical trial of Agios' AG-221 for acute myeloid leukemia with a specific mutation, three out of the seven patients who completed the study experienced complete remission while the conditions of another three improved. The drug could help reduce the need for bone marrow transplants, said Dr. Eytan Stein, who presented the results at the 2014 American Association for Cancer Research meeting.

View Full Article in:

Forbes · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX